Total and high molecular weight adiponectin and ethnic-specific differences in adiposity and insulin resistance: A cross-sectional study

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Sulistyoningrum, Dian C ^a   Gasevic, Danijela ^b   Lear, Scott A ^b,c   Ho, Joe ^a   Mente, Andrew ^d   Devlin, Angela M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

^c Division of Cardiology   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Ethnicity; High molecular weight adiponectin; Insulin resistance; Visceral adipose tissue

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH MOLECULAR WEIGHT ADIPONECTIN; INSULIN; UNCLASSIFIED DRUG;

ABORIGINE; ADULT; ARTICLE; BODY FAT; BODY MASS; CANADA; CHINESE; CLINICAL ASSESSMENT TOOL; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; ETHNIC DIFFERENCE; EUROPE; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT INSULIN RESISTANCE; HUMAN; IMAGE ANALYSIS; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; QUANTITATIVE ANALYSIS; SOCIOECONOMICS; SOUTH ASIA; SUBCUTANEOUS TISSUE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADIPONECTIN; ADIPOSITY; ADULT; AMERICAN NATIVE CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BODY MASS INDEX; CANADA; CHINA; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; RISK FACTORS; SUBCUTANEOUS FAT; TOMOGRAPHY, X-RAY COMPUTED; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84887350685     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-170     Document Type: Article

References (30)

1. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 1990, 113(12):909-915. 10.7326/0003-4819-113-12-909, 2240915.
2. Young TK, Reading J, Elias B, O'Neil JD. Type 2 diabetes mellitus in Canada's first nations: status of an epidemic in progress. CMAJ 2000, 163(5):561-566. 80466, 11006768.
3. Razak F, Anand S, Vuksan V, Davis B, Jacobs R, Teo KK, Yusuf S. Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. Int J Obes (Lond) 2005, 29(6):656-667. 10.1038/sj.ijo.0802937, 15782225.
4. Weber MB, Oza-Frank R, Staimez LR, Ali MK, Venkat Narayan KM. Type 2 diabetes in asians: prevalence, risk factors, and effectiveness of behavioral intervention at individual and population levels. Ann Rev Nutr 2012, 32(1):417-439.
5. Cook JR, Semple RK. Hypoadiponectinemia cause or consequence of human " insulin resistance" ?. J Clin Endocrinol Metab 2010, 95(4):1544-1554. 10.1210/jc.2009-2286, 20164291.
6. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006, 55(1):249-259. 10.2337/diabetes.55.01.06.db05-1105, 16380500.
7. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006, 29(6):1357-1362. 10.2337/dc05-1801, 16732021.
8. Ferris WF, Naran NH, Crowther NJ, Rheeder P, Van der Merwe L, Chetty N. The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Horm Metab Res 2005, 37(11):695-701. 10.1055/s-2005-870580, 16308839.
9. Martin M, Palaniappan LP, Kwan AC, Reaven GM, Reaven PD. Ethnic differences in the relationship between adiponectin and insulin sensitivity in south asian and caucasian women. Diabetes Care 2008, 31(4):798-801. 10.2337/dc07-1781, 18202246.
10. Mente A, Razak F, Blankenberg S, Vuksan V, Davis AD, Miller R, Teo K, Gerstein H, Sharma AM, Yusuf S, et al. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 2010, 33(7):1629-1634. 10.2337/dc09-1392, 2890372, 20413520.
11. Tchernof A, Després J-P. Pathophysiology of human visceral obesity: an update. Physiol Rev 2013, 93(1):359-404. 10.1152/physrev.00033.2011, 23303913.
12. Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham CL. Visceral adipose tissue accumulation differs according to ethnic background: results of the multicultural community health assessment trial (M-CHAT). Am J Clin Nutr 2007, 86(2):353-359.
13. Khoo CM, Sairazi S, Taslim S, Gardner D, Wu Y, Lee J, Van Dam RM, Shyong Tai E. Ethnicity modifies the relationships of insulin resistance, inflammation, and adiponectin with obesity in a multiethnic asian population. Diabetes Care 2011, 34(5):1120-1126. 10.2337/dc10-2097, 3114514, 21464462.
14. Hulver MW, Saleh O, MacDonald KG, Pories WJ, Barakat HA. Ethnic differences in adiponectin levels. Metabolism 2004, 53(1):1-3. 10.1016/j.metabol.2003.07.002, 14681833.
15. Hanley AJG, Bowden D, Wagenknecht LE, Balasubramanyam A, Langfeld C, Saad MF, Rotter JI, Guo X, Chen Y-DI, Bryer-Ash M, et al. Associations of adiponectin with body Fat distribution and insulin sensitivity in nondiabetic hispanics and african-americans. J Clin Endocrinol Metab 2007, 92(7):2665-2671. 10.1210/jc.2006-2614, 17426091.
16. Bidulescu A, Liu J, Hickson DA, Hairston KG, Fox ER, Arnett DK, Sumner AE, Taylor HA, Gibbons GH. Gender differences in the association of visceral and subcutaneous adiposity with adiponectin in african americans: the jackson heart study. BMC Cardiovasc Disord 2013, 13(9). 10.1186/1471-2261-13-9.
17. Lear SA, Birmingham CL, Chockalingam A, Humphries KH. Study design of the multicultural community health assessment trial (M-CHAT): a comparison of body fat distribution in four distinct populations. Ethn Dis 2006, 16(1):96-100.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419. 10.1007/BF00280883, 3899825.
19. Shah A, Hernandez A, Mathur D, Budoff MJ, Kanaya AM. Adipokines and body fat composition in south asians: results of the metabolic syndrome and atherosclerosis in south asians living in america (MASALA) study. Int J Obes 2012, 36(6):810-816.
20. Nayak S, Maharaj N, Fatt L-A. Association between altered lipid profile, body mass index, low plasma adiponectin and varied blood pressure in trinidadian type 2 diabetic and non-diabetic subjects. Ind J Med Sci 2012, 66(9-10):214-221.
21. Lear SA, Kohli S, Bondy GP, Tchernof A, Sniderman AD. Ethnic variation in Fat and lean body mass and the association with insulin resistance. J Clin Endocrinol Metab 2009, 94(12):4696-4702. 10.1210/jc.2009-1030, 19820012.
22. Maple-Brown LJ, Cunningham J, Zinman B, Mamakeesick M, Harris SB, Connelly PW, Shaw J, O'Dea K, Hanley AJ. Cardiovascular disease risk profile and microvascular complications of diabetes: comparison of indigenous cohorts with diabetes in australia and canada. Cardiovasc Diabetol 2012, 11(30). 10.1186/1475-2840-1111-1130.
23. Wu X, Motoshima H, Mahadev K, Stalker TJ, Scalia R, Goldstein BJ. Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary Rat adipocytes. Diabetes 2003, 52(6):1355-1363. 10.2337/diabetes.52.6.1355, 12765944.
24. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001, 7(8):947-953. 10.1038/90992, 11479628.
25. Siitonen N, Pulkkinen L, Lindström J, Kolehmainen M, Schwab U, Eriksson JG, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M. Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention Study. Cardiovasc Diabetol 2011, 10(83). 10.1186/1475-2840-1110-1183.
26. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003, 46(4):459-469.
27. Cote M, Mauriege P, Bergeron J, Almeras N, Tremblay A, Lemieux I, Despres JP. Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol Metab 2005, 90(3):1434-1439.
28. Park K-G, Park KS, Kim M-J, Kim H-S, Suh Y-S, Ahn JD, Park K-K, Chang Y-C, Lee I-K. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract 2004, 63(2):135-142. 10.1016/j.diabres.2003.09.010, 14739054.
29. Kovacova Z, Tencerova M, Roussel B, Wedellova Z, Rossmeislova L, Langin D, Polak J, Stich V. The impact of obesity on secretion of adiponectin multimeric isoforms differs in visceral and subcutaneous adipose tissue. Int J Obes 2012, 36(10):1360-1365.
30. Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, Rosato FE, Goldstein BJ. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 2002, 87(12):5662-5667. 10.1210/jc.2002-020635, 12466369.